Thursday 22 September
Please find below the programme schedule for Thursday 22 September 2022.
Meet the experts session 1
08:00
M1.1 Diagnostic Rounds Interactive session for diagnosis of emerging and re-emerging fungal infections
Birgit Willinger, Austria and Jurgen Prattes, Germany
08:00
M1.2 Human Pythiosis
Ariya Chindamporn, Thailand and Rongpong Plongla, Thailand
08:00
M1.3 Standardization of diagnostic mycology laboratories
Malcolm Richardson, UK and Amir Seyedmousavi, USA
09:00
Key note (P3): Progress in fungal diagnostics: the pros and cons
Cornelia Lass Flörl, Austria
10:00
Break
Parallel session 4
Parallel session 4 will take place from 10:30 hrs. until 12:00 hrs. and consists of five symposia.
S4.1 Treatment of Rare Mould Infections in 2021: The role of new and old antifungals
Chair: Martin Hoenigl, Austria
10:30
S4.1a Fusariosis: MICs, Mono versus CombinationTherapy and Fosmanogepix
Martin Hoenigl, Austria
10:50
S4.1b Lomentosporiosis: From Voriconazole/Terbinafine combination to Olorofim
Danila Seidel, Gemany
11:10
S4.1c Rasamsonia and Paecilomyces/Purpureocillium: Current state of the art and new treatment options
Rosanne Sprute, Germany
11:30
S4.1d In vitro activity of eight antifungals against 3,343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive Mycosis and Antifungals
Dea Garcia-Hermoso, France
12:45
Q&A with all speakers
S4.2 Advances in Diagnosis of Invasive fungal infection
Chair: Boualem Sendid, France
10:30
S4.2a Advances in the diagnosis of invasive fungal infection: invasive candidiasis
Boualem Sendid, France
10:50
S4.2b Invasive aspergillosis
Katrien Lagrou, Belgium
11:10
S4.2c Invasive mucormycosis
Hariprasath Prakash, India
11:30
S4.2d Efficacy of LD Bio Aspergillus ICT Lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis
Animesh Ray, India
11:45
Q&A with all speakers
S4.3 Emergent species of the Candida genus
Chair: Neil Gow, UK, Niranjan Nayak, India
10:30
S4.3a Candida tropicalis - molecular mechanism of drug resistance and detection
Anup Ghosh, India
10:50
S4.3b Candida glabrata-host interaction
Bernhard Hube, Germany
11:10
S4.3c Candida glabrata, new tools to study stress, pathogenesis and drug resistance’
Jane Usher, UK
11:30
S4.3d Mechanism of fluconazole resistance in Candida vulturna, a member of the Candida haemulonii complex of multidrug resistant yeasts
Guillermo Garcia Effron, Argentina
11:45
Q&A with all speakers
S4.4 International Histoplasmosis Advocacy group (IHAG)
Chairs: Beatriz Gomez, Colombia, Tom Chiller, USA and Diego Caceres, USA
10:30
S4.4a Global burden of histoplasmosis
Antoine Adenis, France
10:50
S4.4b Progress on iHAG “100 by 25”
Tom Chiller, USA
11:10
S4.4c Histoplasmosis outside the traditional endemic region
Rita Oladele, Nigeria
11:30
S4.4d
TBD
11:45
Q&A with all speakers
S4.5 Mycetoma Clinical Trial on fosravuconazole treatment in eumycetoma– Top Line Results
Chair: Ed Zijlstra, Switzerland
10:30
S4.5a A randomized, double blind phase ii proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan – Top Line Results
Ahmed Hassan Fahal, Sudan
10:50
S4.5b A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan – PK results
Borna Nyaoke, Kenya
11:05
S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma
Wendy van de Sande, Netherlands
11:20
S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard
Emmanuel Edwar Siddig, Sudan
11:35
General discussion
12:00
Lunch and Poster session 2
Key note 4 (P4): COVID-19 associated fungal infections
Martin Hoenigl, Austria
Parallel session 5
Parallel session 5 will take place from 15:00 hrs. until 16:30 hrs. and consists of five symposia.
S5.1 Antifungal Resistance
Chairs: Jacques Meis, Netherlands and Danila Seidel, Germany
15:00
S5.1a Candida Tropicalis: Increasing Resistance
Yee-Chun Cheng, Taiwan
15:20
S5.1b Azole-resistance in Aspergillus fumigatus: Clinical implications in haematological patients
Danila Seidel, Germany
S5.1c Resistance in rare fungal infections
Ashutosh Singh, India
16:00
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis
Anup Ghosh, India
16:15
Q&A with all speakers
S5.2 The threat of invasive fungal infections: the first WHO list of fungal pathogens of public health importance
Chairs: TBD
15:00
S5.2a Development of WHO priority pathogens list of public health importance
Justin Beardsley, Australia
15:20
S5.2b AMR fungal infections global burden: surveillance challenges, gap & opportunities: WHO GLASS pilot
Daniel Marcano,WHO HQ
15:40
S5.2c WHO first antifungals clinical & preclinical pipeline review
TBD
16:00
S5.2d Current state of research and development of antifungals treatment and diagnostics
Orla Morrissey, Australia
16:15
Q&A with all speakers
S5.3 Cellular pleomorphism and fungal virulence
Chairs: Rupinder Kaur, India and Dee Carter, Australia
15:00
S5.3a Unraveling the genetic determinants of virulence in Cryptococcus
Katrina Jackson, USA
S5.3b Fungal spores: Initiators of colonization and infection
Tim Baltussen, Netherlands
15:40
S5.3c Investigating the link between pleomorphism and virulence in Cryptococcus
Kenya Fernandes, Australia
16:00
S5.3d How mitochondrial complex I proteins in Candida albicans moderate phagocytosis and the production of pro-inflammatory cytokines in murine macrophages and dendritic cells
Xiaodong She, China
16:15
Q&A with all speakers
S5.4 Free oral paper session
Chair: TBD
15:00
S5.4a Cutaneous manifestations of deep fungal infections: a retrospective study from one tertiary hospital
Peiran Chen, China
15:20
S5.4b Genomic variation structure in clinical isolate collections alters benefits of association screening: a study of Cryptococcus neoformans var. grubii in Colombia
Oliver Keatinge Clay, Colombia
15:40
S5.4c Isolation of keratinophilic fungi of the genus Microsporum from the soils of Moscow, Russia
Marina Manoyan, Russia
16:00
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy
Liuliu Sun, China
S5.5 Genomic Epidemiology of Fungal Infections
Chairs: Anastasia, Litvintseva, USA and Nancy Chow, USA
15:00
S5.5a Standing Up FungiNet: Genomic epidemiology and surveillance of fungal diseases
Nancy Chow, USA
15:20
S5.5b WGS typing for outbreak investigations
Alexandre Alanio, France
15:40
S5.5c Future of molecular typing in fungi
David Engelthaler, USA
16:00
S5.5d SARS-CoV-2 associated Invasive fungal sinus infections; The Sri Lankan perspective
Liyanage Shamithra
16:15
Q&A with all speakers
16:30
BReak
Parallel session 6
Parallel session 6 will take place from 16:45 hrs. until 18:15 hrs. and consists of five symposia.
S6.1 Antifungal Prophylaxis in Children with Cancer and HSCT
Chair: Andreas Groll, Germany
16:45
S6.1a What do pediatric guidelines recommend?
Adilia Warris, UK
17:05
S6.1b Challenges in antifungal prophylaxis in the real life setting
TBD
17:25
S6.1c Potential utility of extended dosing regimens
Andreas Groll, Germany
17:45
S6.1d First case report of paediatric blood stream infection by Candida magnoliae in a known case of B cell ALL post induction chemotherapy in Central India
Subhasish Bhadra, India
18:00
Q&A with all speakers
S6.2 Resurgence of dermatophytic infections
Chairs: Rosalie Sacheli, Belgium and Shivaprakas Rudramurthy, India
16:45
S6.2a The Indian epidemic: clinical and epidemiologic aspects
Shiham Verma, India
17:05
S6.2b In vitro susceptibility testing of dermatophytes: towards standardisation
Ditte Saunte, Denmark
17:25
S6.2c Dermatophyte antifungal resistance
Eric Dannaoui, France
17:45
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with african hedgehogs as family pets
Alexandro Bonifaz, Mexico
18:00
Q&A with all speakers
S6.3 Fungal adaptation and evolution
Chair: Sijmen Schoustra, Netherlands
16:45
S6.3a Genetics and genomics of adaptive change in Aspergillus
Sijmen Schoustra, Netherlands
17:05
S6.3b Aspergillus fumigatus resistance development to triazoles in compost; an experimental evolution model
Jianhua Zhang, Netherlands
17:25
S6.3c Long-term adaptation of Aspergillus to low resource conditions resulting in non-sporulation mutant types
Krithi Nandimath, India
17:45
S6.3d Candida albicans commensalism in the oral mucosa is favoured by limited virulence and metabolic adaptation
Salomé LeibundGut-Landmann, Switzerland
18:00
Q&A with all speakers
S6.4 One health approach for endemic mycoes in the Americas
Chairs: Flavio Queiroz-Telles, Brazil and Arnaldo Lopes Colombo, Brazil
16:45
S6.4a Chromoblastomycosis as occupational disease
Daniel Wagner, Brazil
17:00
S6.4b Sporotrichosis in pediatric patients
Flavio Queiroz-Telles, Brazil
17:15
S6.4c Primary cutaneous implantation coccidioidomycosis
Alexandro Bonifaz, Mexico
17:30
S6.d Coccidioidomycosis & climate change
Tom Chiller, USA
17:45
S6.4e Discovering new histoplasmosis patients in LATAM
Diego Caceres, USA
18:00
Q&A with all speakers
S6.5 Efforts of improving the management of mycetoma: working towards the 2030 goals
Chairs: Wendy van de Sande, Netherlands and Ahmed Hassan Fahal, Sudan
16:45
S6.5a Metagenomic analysis of Sennar and White Nile states in Sudan to identify mycetoma causative agents in the surroundings
Sahar Bakhiet, Sudan
17:05
S6.5b Genomics and metagenomics of Madurella mycetomatis
Anastasia Litvintseva, USA
17:25
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain
Wendy van de Sande, Netherlands
17:45
S6.5d Molecular identification of mycetoma causative agents from patients in hospital setting in Senegal
Doudou Sow, Senegal
18:00
Q&A with all speakers
18:15
Key note (P5): Advances in the field of aspergillosis
Paul Verweij, Netherlands
19:00
Young ISHAM dinner and party